Tissue Banking Market Research Report Forecast till 2030

List of Tables

Market Overview

Tissue Banking Market is anticipated to register a healthy CAGR of 8.5% during the review period.

The rising predominance of constant sicknesses like malignant growth, coronary illness, and diabetes infection significantly influence all around the world as well as raises the interest for cutting edge treatment options for the treatment of persistent sickness. As rising gamble of constant sickness appears to be the best treatment elective for tissue banking. What's more, according to the American Malignant growth Society, around 1.9 million new instances of disease were analysed in the US. Moreover, coronary illness is considered as the main source of death for ladies and men. One individual kick the bucket like clockwork in the US from cardiovascular illness. Around 4,66,566 individuals experienced coronary illness in the US. Coronary illness costs the US around USD 239.9 billion consistently from 2018 to 2019. Hence, the rising commonness of coronary illness disease, and diabetes is expanding the interest in tissue banking so central participants are distinctly interested in the research and improvement movement for new item advancement which pushes the development of tissue banking.

Market Segmentation

The Tissue Banking Market segmentation, based on type, includes media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, and others.

The Tissue Banking Market segmentation is based on tissue types that include heart valve, cornea, bone, skin, brain & spinal cord, and others.

The Tissue Banking Market segmentation is based on applications that include therapeutics, medical research, and others.

Regional Insights

North America represented the biggest market share in 2022 attributable to the North America is supposed to order the biggest market share because of the rising propensity of egg frozen in the US, accessibility of advance innovation, expanding medical care framework, created monetary condition boos the development of tissue banking in the North America region.

Europe tissue banking market is supposed to represent the second-biggest market share because of the development of the market are expanding mechanical turn of events and item advancement, rising research and improvement movement, expanding event of life threating sickness like coronary illness, malignant growth, and others. Moreover, expanding quantities of organ contributors across the region is driving the development of tissue banking.

The Asia-Pacific tissue banking market is anticipated to register a CAGR of 6.90% during the review period. This is because of expanding venture by unfamiliar organizations, colossal ongoing sickness populace, expanding entrance of frozen eggs are driving the development of tissue banking in the Asia-pacific region.

Latin America holds the significant market share in the middle east and Africa region because of the region's development is credited to a developing utilization of tissue banking, rising mindfulness about the organ gift for saving other life, developing new mechanical turn of events and advance clinical office across the region are help the development of tissue banking in region.

Major Players

The key market players are Applied Biosystems, Custom Biogenic Systems (US), Invitrogen, Thermo Scientific, Fisher Scientific, Cesca Therapeutics, Inc. (US), Unity Lab Services, BioLife Solutions (US), Atlanta Biologics Pvt. Ltd. (US), Lifeline Scientific (US), BioCision, core dynamics GmbH (US), Taylor-Wharton (US), and Panasonic Holdings Corporation (Japan).

Product Code: MRFR/HC/10884-HCR

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. MARKET ATTRACTIVENESS ANALYSIS
- 1.1.1. GLOBAL TISSUE BANKING MARKET, BY TYPE
- 1.1.2. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
- 1.1.3. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
- 1.1.4. GLOBAL TISSUE BANKING MARKET, BY REGION

2. MARKET INTRODUCTION

2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.3. MARKET STRUCTURE

3. RESEARCH METHODOLOGY

3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
- 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
- 3.6.1. BOTTOM-UP APPROACH
- 3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION

4. MARKET DYNAMICS

4.1. INTRODUCTION
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

5.1. VALUE CHAIN ANALYSIS
5.2. PORTER'S FIVE FORCES ANALYSIS
- 5.2.1. BARGAINING POWER OF SUPPLIERS
- 5.2.2. BARGAINING POWER OF BUYERS
- 5.2.3. THREAT OF NEW ENTRANTS
- 5.2.4. THREAT OF SUBSTITUTES
- 5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
- 5.3.1. MARKET IMPACT ANALYSIS
- 5.3.2. REGIONAL IMPACT
- 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL TISSUE BANKING MARKET, BY TYPE

6.1. OVERVIEW
6.2. MEDIA AND CONSUMABLE
6.3. CRYOPRESERVATION EQUIPMENT
6.4. THAWING EQUIPMENT
6.5. QUALITY CONTROL EQUIPMENT
6.6. OTHERS

7. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE

7.1. OVERVIEW
7.2. HEART VALVE
7.3. CORNEA
7.4. BONE
7.5. SKIN
7.6. BRAIN & SPINAL CORD
7.7. OTHERS

8. GLOBAL TISSUE BANKING MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. THERAPEUTICS
8.3. MEDICAL RESEARCH
8.4. OTHERS

9. GLOBAL TISSUE BANKING MARKET, BY REGION

9.1. OVERVIEW
9.2. NORTH AMERICA
- 9.2.1. US
- 9.2.2. CANADA
9.3. EUROPE
- 9.3.1. GERMANY
- 9.3.2. FRANCE
- 9.3.3. UK
- 9.3.4. ITALY
- 9.3.5. SPAIN
- 9.3.6. REST OF EUROPE
9.4. ASIA-PACIFIC
- 9.4.1. CHINA
- 9.4.2. INDIA
- 9.4.3. JAPAN
- 9.4.4. AUSTRALIA
- 9.4.5. SOUTH KOREA
- 9.4.6. REST OF ASIA-PACIFIC
9.5. REST OF THE WORLD
- 9.5.1. MIDDLE EAST
- 9.5.2. AFRICA
- 9.5.3. LATIN AMERICA

10. COMPETITIVE LANDSCAPE

10.1. INTRODUCTION
10.2. COMPETITIVE ANALYSIS
10.3. MARKET SHARE ANALYSIS
10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL TISSUE BANKING MARKET
10.5. COMPETITIVE BENCHMARKING
10.6. LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL TISSUE BANKING MARKET
10.7. KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.7.1. NEW PRODUCT LAUNCH
- 10.7.2. MERGER & ACQUISITION
- 10.7.3. JOINT VENTURES
10.8. MAJOR PLAYERS FINANCIAL MATRIX
- 10.8.1. SALES & OPERATING INCOME, 2022
- 10.8.2. MAJOR PLAYERS R&D EXPENDITURE, 2022

11. COMPANY PROFILES

11.1. THERMO FISHER SCIENTIFIC INC
- 11.1.1. COMPANY OVERVIEW
- 11.1.2. FINANCIAL OVERVIEW
- 11.1.3. TYPES OFFERED
- 11.1.4. KEY DEVELOPMENTS
- 11.1.5. SWOT ANALYSIS
- 11.1.6. KEY STRATEGIES
11.2. BIOLIFESOLUTIONS
11.3. LIFELINE SCIENTIFIC
11.4. BIOCISION, CESCA THERAPEUTICS, INC
11.5. CORE DYNAMICS GMBH
11.6. CUSTOM BIOGENIC SYSTEMS
11.7. ATLANTA BIOLOGICS PVT. LTD
11.8. TAYLOR-WHARTON
11.9. PANASONIC HOLDINGS CORPORATION

12. APPENDIX

12.1. REFERENCE REPORT
12.2. RELATED REPORTS